|
|
Comparison of Clinical Efficacy between Extracorporeal Aortic Stent Fenestration and Castor Branch Covered Stent TEVAR for LSA Reconstruction in Treatment of Aortic Arch Lesions |
LI Xiaoheng, LI Yanping, FU Xiaoke, et al |
Luoyang Central Hospital, Luoyang Henan 471000 |
|
|
Abstract 【Objective】To compare the clinical efficacy of extracorporeal aortic stent fenestration and Castor branch covered stent for thoracic endovascular aortic repair(TEVAR) reconstructing the left subclavian artery(LSA) in the treatment of aortic arch lesions. 【Methods】A total of 71 patients with aortic arch lesions admitted to our hospital from January 2020 to January 2023 were selected and divided into an extracorporeal window group(aortic stent extracorporeal window opening, n=51) and an extracorporeal branch group(Castor branch covered stent TEVAR reconstruction LSA, n=21) based on different LSA reconstruction methods. The perioperative indicators, surgical success rate, and postoperative complication incidence of the two groups of patients were compared; The follow-up prognosis after 1 year showed the remodeling of the sandwich cavity and the patient's false lumen thrombosis after the dissection surgery. 【Results】The surgical time, success rate of instrument release, and surgical cost of the external branch group were all higher than those of the external window group(P<0.05). The change rate of true lumen area [R(ATL)] in the L1, L3, and L4 stent segments and the external branch group was higher than that in the external fenestration group(P<0.05); The false lumen area change rate [R(AFL)] and true lumen diameter change rate [R(DTL)] in the L3 external branch group of the stent segment were higher than those in the in vitro fenestration group, while the L4 R(DTL) was higher than those in the in vitro fenestration group(P<0.05). There was no statistically significant difference in the degree of false lumen thrombosis between the two groups of patients in the stent and non stent segments(P>0.05). 【Conclusion】Both extracorporeal stent fenestration and Castor branch coated stent TEVAR for LSA reconstruction in treatment of aortic arch lesions have good safety and effectiveness. Castor branch coated stent TEVAR has a shorter operating time and better proximal stent remodeling effect than extracorporeal fenestration TEVAR.
|
Received: 25 February 2024
|
|
|
|
|
[1] 陈明江,姜建彪,李梅. 多层螺旋CT血管造影表现对主动脉夹层患者院内生存状况的影响[J].中国现代医学杂志,2019,29(10):105-108. [2] 罗明尧,舒畅,陈冬,等. 以主动脉夹层和腹主动脉瘤为例谈中国主动脉疾病诊疗研究现状[J].临床外科杂志,2021,29(12):1196-1199. [3] 莫凡迪,王利新,符伟国. 纳米材料靶向递药治疗实验性腹主动脉瘤模型的研究进展[J].中华实验外科杂志,2022,39(9):1810-1815. [4] 郭鹏程,张雷,舒畅,等. 血管内超声在主动脉腔内治疗中的应用与进展[J].中国血管外科杂志(电子版),2023,15(1):71-74. [5] 阳建政,李嘉怡,薛向花,等. 经胸超声心动图对主动脉夹层的漏误诊分析[J].临床超声医学杂志,2020,22(7):554-555. [6] 毛乐,乔永辉,栾靖旸,等. 开窗技术数值模拟在主动脉弓部病变中的应用[J].中国临床医学,2021,28(3):375-380. [7] 李奇航,赵强. 杂交技术治疗主动脉弓部病变的研究进展[J].国际心血管病杂志,2020,47(5):260-263. [8] 化召辉,周保宁,李震. 3D打印技术在辅助主动脉弓部开窗中的应用[J].中国血管外科杂志(电子版),2023,15(1):28-32. [9] 万乔浩,张小明. 主动脉弓原位开窗术的应用和进展[J].中华老年多器官疾病杂志,2022,21(8):630-633. [10] 姚诗华,陈旭,郑奇军. Castor分支支架技术在治疗主动脉弓部疾病的应用进展[J].中国血管外科杂志(电子版),2022,14(2):185-188. [11] 秘家学,戴向晨,罗宇东,等. 预开窗与外分支主动脉腔内修复术治疗主动脉病变的近期效果分析[J].中华医学杂志,2021,101(6):405-409. [12] 王慧勇,谢年谨,丁焕宇,等. 主动脉支架体外开窗技术在主动脉弓部疾病腔内修复术中应用的早期经验[J].中国介入心脏病学杂志,2023,31(1):39-43. [13] 孙玉桂,胡长付,孙江滨. 国产新型分支支架在胸主动脉疾病中的临床应用[J].国际心血管病杂志,2020,47(3):182-185. [14] 卢楷,孙晓凡,彭臣,等. 开窗技术与平行支架技术治疗主动脉弓部病变的血流动力学研究[J].医用生物力学,2023,38(2):360-367. [15] 孙玉桂,张显岚,孙江滨. “单向”导丝技术结合新型Castor分支支架植入在Stanford B型主动脉夹层患者胸主动脉腔内修复术中的应用效果及体会[J].实用心脑肺血管病杂志,2020,28(6):68-73. |
|
|
|